NFE2L2 and diabetes mellitus: In addition, baicalin reduces ROS and inflammation via Nrf2 activation in human umbilical vein vascular endothelial cells (HUVECs) stimulated with high glucose or mice with streptozotocin (STZ)-induced diabetes.